DG vs PACB · P/E 15, rev $40.61B vs rev $38.4M
Dollar General Corporation (DG) versus Pacific Biosciences of California (PACB) — a side-by-side from cached financials, not a winner call.
Dollar General Corporation (DG) is a discount stores company listed on US.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Latest reported DG revenue for 2025-01-31 was $40.61B. Net income was $1.13B. Revenue was up 5.0% from 2024-02-02 to 2025-01-31. DG currently screens at market cap $22.87B and trailing P/E 14.7.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
DG currently screens at market cap $22.87B and trailing P/E 14.7. PACB currently screens at market cap $387.1M.
Not investment advice. Open the DG and PACB stock pages for the full models.
Not investment advice.